checkAd

     105  0 Kommentare Redx Pharma Plc Shares now trading on JP Jenkins - Seite 2

     

    Veronika Oswald, Commercial Director of JP Jenkins said: “Red’s move from AIM to the JP Jenkins venue represents a significant step forward in our journey towards accessibility and liquidity for their investors. This transition underscores our commitment to fostering a dynamic and thriving investment environment. We're thrilled to embark on this new chapter with Redx, confident in the opportunities it will unlock for both companies."

     

    For further information, please contact:

     

     

    JP Jenkins Limited

    Redx Pharma Plc

    Contact: Veronika Oswald (Director)

    Caitlin Pearson (Head of Communications)

    +44 (0)20 7469 0937

    01625 469 918

    IR@redxpharma.com

     

     

     



    Dissemination of a CORPORATE NEWS, transmitted by EQS Group.
    The issuer is solely responsible for the content of this announcement.


    End of Announcement - EQS News Service

    1893571  01-May-2024 

    fncls.ssp?fn=show_t_gif&application_id=1893571&application_name=news&site_id=wallstreet~~~257e03b8-9cbc-48b8-b6a5-ec526abf7b8e
    Seite 2 von 2



    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    Redx Pharma Plc Shares now trading on JP Jenkins - Seite 2 JP Jenkins Ltd Redx Pharma Plc Shares now trading on JP Jenkins 01-May-2024 / 07:03 GMT/BST The issuer is solely responsible for the content of this announcement. 1st May 2024 JPJ: REDX ISIN: GB00BSNB6S51 Redx Pharma Plc   Shares now trading on JP …